AI Breast Cancer Risk Tool Clairity Breast Rolls Out Nationwide

Clairity Breast, an AI-based tool predicting five-year breast cancer risk, is being deployed nationwide. The rollout marks a shift toward AI-assisted preventive screening, though expert validation and clinical integration remain ongoing. This matters as it could reshape screening protocols and resource allocation in oncology.